Open Access Research article

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

David H Adams*, Bruce J Kinon, Simin Baygani, Brian A Millen, Isabella Velona, Sara Kollack-Walker and David P Walling

BMC Psychiatry 2013, 13:143  doi:10.1186/1471-244X-13-143

Article Metrics

2707
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 71 accesses
  • Last 365 days: 963 accesses
  • All time: 2707 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information